Percutaneous coronary intervention using iso-osmolar contrast agent in an end-stage renal failure patient: a case report
Managing acute myocardial infarction (AMI) in end-stage renal failure (ESRF) patients poses challenges, particularly the risk of contrast-induced nephropathy (CIN) during percutaneous coronary intervention (PCI). This case highlights the successful use of iodixanol, an iso-osmolar contrast agent, in...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Sciendo
2025-06-01
|
| Series: | Romanian Journal of Cardiology |
| Subjects: | |
| Online Access: | https://doi.org/10.2478/rjc-2025-0004 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Managing acute myocardial infarction (AMI) in end-stage renal failure (ESRF) patients poses challenges, particularly the risk of contrast-induced nephropathy (CIN) during percutaneous coronary intervention (PCI). This case highlights the successful use of iodixanol, an iso-osmolar contrast agent, in an ESRF patient who declined dialysis with no renal function deterioration. It underscores the potential of iodixanol in safely managing high-risk patients, offering insights for clinical practice. |
|---|---|
| ISSN: | 2734-6382 |